Belderbos José, Sonke Jan Jakob
Department of Radiation Oncology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121 1066 CX, Amsterdam, The Netherlands.
Expert Rev Anticancer Ther. 2009 Oct;9(10):1353-63. doi: 10.1586/era.09.118.
External-beam radiotherapy, often combined with chemotherapy, is the treatment of choice for locally advanced inoperable lung cancer. Locoregional control and disease-free survival, however, are limited with the current clinically applied treatment strategies. An important factor is the inability to deliver sufficiently high dose levels, mainly caused by the fact that the limited geometrical accuracy impedes further dose escalation owing to risk of complications. Higher conformality of the planned dose distributions and higher levels of accuracy in radiotherapy delivery reduces the amount of normal tissues irradiated, such that the tumor and pathologic lymph nodes can be safely irradiated to higher doses. In this review we describe recent developments in imaging, treatment planning and treatment delivery that have the potential to increase the efficacy of lung cancer radiation therapy. Respiratory-correlated imaging techniques eliminate respiratory-induced artifacts and produces 4D scans representing the patient's anatomy (CT) and biology (18-fludeoxyglucose [(18)FDG]-PET) over the respiratory cycle. Moreover, (18)FDG-PET scans provide information on the heterogeneous tumor characteristics. Intensity-modulated radiotherapy planning techniques produce highly conformal dose distributions tailored to the patient-specific respiratory motion patterns and, possibly, tumor characteristics. Image-guided radiotherapy utilizes repetitive imaging in the treatment room to measure and correct tumor misalignments. Finally, adaptive radiotherapy monitors the patient over the course of treatment and allows for adaptive treatment-plan modifications to individualize the treatment to the observed patient-specific changes. These techniques thus allow the delivery of higher doses of irradiation that yield a greater probability of complete response, higher tumor control and better survival in irradiated lung cancer patients.
外照射放疗通常与化疗联合使用,是局部晚期不可切除肺癌的首选治疗方法。然而,目前临床应用的治疗策略在局部区域控制和无病生存率方面存在局限性。一个重要因素是无法给予足够高的剂量水平,这主要是由于有限的几何精度因并发症风险而阻碍了进一步的剂量增加。计划剂量分布的更高适形性和放疗实施的更高精度水平减少了受照射正常组织的数量,从而可以安全地将肿瘤和病理性淋巴结照射到更高剂量。在本综述中,我们描述了成像、治疗计划和治疗实施方面的最新进展,这些进展有可能提高肺癌放射治疗的疗效。呼吸相关成像技术消除了呼吸引起的伪影,并生成了代表患者在呼吸周期中的解剖结构(CT)和生物学特征(18-氟脱氧葡萄糖[(18)FDG]-PET)的4D扫描图像。此外,(18)FDG-PET扫描提供了关于肿瘤异质性特征的信息。调强放疗计划技术可根据患者特定的呼吸运动模式以及可能的肿瘤特征生成高度适形的剂量分布。图像引导放疗利用治疗室内的重复成像来测量和纠正肿瘤的错位。最后,自适应放疗在治疗过程中对患者进行监测,并允许进行自适应治疗计划修改,以使治疗个性化,以适应观察到的患者特定变化。因此,这些技术能够给予更高剂量的照射,从而在接受放疗的肺癌患者中产生更高的完全缓解概率、更高的肿瘤控制率和更好的生存率。